Ropivacaine and Fentanyl for Labor Epidural Initiation

Recruiting now · Phase 3

Conditions studied: Pregnancy, Labor and Delivery, Labor Analgesia

In brief

This study is being done to determine the most effective dose of medicine to use to initially provide effective pain relief within the first 30 minutes of receiving an epidural for pain labor during labor. The study team will also study any side effects related to the epidural medication and patients' satisfaction with the quality of pain relief after receiving the epidural.

Key facts

Study ID

NCT07076368

Run by

University of California, San Francisco

People needed

50

Starts

2025-10-24

Expected to finish

2026-07-31

Last updated by the study team

2026-01-27

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Patients with singleton vertex pregnancies in active labor (latent or spontaneous labor or after induction of labor)
• Cervical dilatation between 2 and 7 cm
• Requesting neuraxial labor analgesia
• Age 18 or older

You may not qualify if…

• Significant obstetric disease (e.g., pre-eclampsia, major cardiac disease)
• Chronic pain or chronic opioid use
• BMI ≥ 50
• Multiple gestations
• Allergy or anaphylaxis to local anesthetic
• Fetal compromise or non-reassuring fetal trace
• Age under 18
• Inability to speak and understand English or Spanish

Where it is running

• University of California, San Francisco — San Francisco, California, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.